Rac1-mediated signaling plays a central role in secretion-dependent platelet aggregation in human blood stimulated by atherosclerotic plaque

Journal of Translational Medicine

Volumn 8, Issue , 2010, Pages

  Dwivedi, Suman ^a   Pandey, Dharmendra ^a,c   Khandoga, Anna L ^a   Brandl, Richard ^b   Siess, Wolfgang ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b Clinic Schwabing   (Germany)

^c MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINO 6 [2 [[4 (DIETHYLAMINO) 1 METHYLBUTYL]AMINO] 6 METHYL 4 PYRIMIDINYL] 2 METHYLQUINOLINE; ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ARGINYLGLYCYLASPARTYLSERINE; COFILIN; COLLAGEN; PADGEM PROTEIN; RAC1 PROTEIN; ACID PHOSPHATASE; ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; AMINOQUINOLINE DERIVATIVE; ISOENZYME; PROSTAGLANDIN SYNTHASE; PYRIMIDINE DERIVATIVE; RAC1 PROTEIN, HUMAN; TARTRATE-RESISTANT ACID PHOSPHATASE;

ARTICLE; ATHEROSCLEROTIC PLAQUE; BLOOD; CELL GRANULE; CONTROLLED STUDY; DRUG TARGETING; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; IC 50; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; THROMBOCYTE RELEASE REACTION; THROMBOCYTE RICH PLASMA; DRUG EFFECT; ENZYMOLOGY; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; SECRETION; THROMBOCYTE; THROMBOSIS;

ACID PHOSPHATASE; ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; AMINOQUINOLINES; BLOOD PLATELETS; COLLAGEN; HUMANS; ISOENZYMES; P-SELECTIN; PLAQUE, ATHEROSCLEROTIC; PLATELET AGGREGATION; PLATELET-RICH PLASMA; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PYRIMIDINES; RAC1 GTP-BINDING PROTEIN; SIGNAL TRANSDUCTION; THROMBOSIS;

EID: 78649686720     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-8-128     Document Type: Article

References (25)

1. Fernandez-Ortiz A, Badimon JJ, Falk E, Fuster V, Meyer B, Mailhac A, Weng D, Shah PK, Badimon L. Characterization of the relative thrombogenicity of atherosclerotic plaque components: implications for consequences of plaque rupture. J Am Coll Cardiol 1994, 23:1562-1569. 10.1016/0735-1097(94)90657-2, 8195515.
2. Vanzanten GH, Degraaf S, Slootweg PJ, Heijnen HFG, Connolly TM, Degroot PG, Sixma JJ. Increased Platelet Deposition on Atherosclerotic Coronary-Arteries. Journal of Clinical Investigation 1994, 93:615-632. 10.1172/JCI117014, 293885, 8113399.
3. Siess W, Zangl KJ, Essler M, Bauer M, Brandl R, Corrinth C, Bittman R, Tigyi G, Aepfelbacher M. Lysophosphatidic acid mediates the rapid activation of platelets and endothelial cells by mildly oxidized low density lipoprotein and accumulates in human atherosclerotic lesions. Proceedings of the National Academy of Sciences of the United States of America 1999, 96:6931-6936. 10.1073/pnas.96.12.6931, 22019, 10359816.
4. Rother E, Brandl R, Baker DL, Goyal P, Gebhard H, Tigyi G, Siess W. Subtype-selective antagonists of lysophosphatidic Acid receptors inhibit platelet activation triggered by the lipid core of atherosclerotic plaques. Circulation 2003, 108:741-747. 10.1161/01.CIR.0000083715.37658.C4, 12885756.
5. Penz S, Reininger AJ, Brandl R, Goyal P, Rabie T, Bernlochner I, Rother E, Goetz C, Engelmann B, Smethurst PA, et al. Human atheromatous plaques stimulate thrombus formation by activating platelet glycoprotein VI. FASEB J 2005, 19:898-909. 10.1096/fj.04-2748com, 15923400.
6. Reininger AJ, Bernlochner I, Penz SM, Ravanat C, Smethurst P, Farndale RW, Gachet C, Brandl R, Siess W. A 2Step Mechanism of Arterial Thrombus Formation Induced by Human Atherosclerotic Plaques. Journal of the American College of Cardiology 2010, 55:1147-1158. 10.1016/j.jacc.2009.11.051, 20223370.
7. Bauer M, Retzer M, Wilde JI, Maschberger P, Essler M, Aepfelbacher M, Watson SP, Siess W. Dichotomous regulation of myosin phosphorylation and shape change by Rho-kinase and calcium in intact human platelets. Blood 1999, 94:1665-1672.
8. Klages B, Brandt U, Simon MI, Schultz G, Offermanns S. Activation of G12/G13 results in shape change and Rho/Rho-kinase-mediated myosin light chain phosphorylation in mouse platelets. J Cell Biol 1999, 144:745-754. 10.1083/jcb.144.4.745, 2132941, 10037795.
9. McCarty OJ, Larson MK, Auger JM, Kalia N, Atkinson BT, Pearce AC, Ruf S, Henderson RB, Tybulewicz VL, Machesky LM, Watson SP. Rac1 is essential for platelet lamellipodia formation and aggregate stability under flow. J Biol Chem 2005, 280:39474-39484. 10.1074/jbc.M504672200, 1395485, 16195235.
10. Soulet C, Gendreau S, Missy K, Benard V, Plantavid M, Payrastre B. Characterisation of Rac activation in thrombin- and collagen-stimulated human blood platelets. FEBS Lett 2001, 507:253-258. 10.1016/S0014-5793(01)02984-2, 11696351.
11. Gratacap MP, Payrastre B, Nieswandt B, Offermanns S. Differential regulation of Rho and Rac through heterotrimeric G-proteins and cyclic nucleotides. J Biol Chem 2001, 276:47906-47913.
12. Akbar H, Kim J, Funk K, Cancelas JA, Shang X, Chen L, Johnson JF, Williams DA, Zheng Y. Genetic and pharmacologic evidence that Rac1 GTPase is involved in regulation of platelet secretion and aggregation. J Thromb Haemost 2007, 5:1747-1755. 10.1111/j.1538-7836.2007.02646.x, 17663742.
13. Pandey D, Goyal P, Dwivedi S, Siess W. Unraveling a novel Rac1-mediated signaling pathway that regulates cofilin dephosphorylation and secretion in thrombin-stimulated platelets. Blood 2009, 114:415-424. 10.1182/blood-2008-10-183582, 19429871.
14. Pleines I, Elvers M, Strehl A, Pozgajova M, Varga-Szabo D, May F, Chrostek-Grashoff A, Brakebusch C, Nieswandt B. Rac1 is essential for phospholipase C-gamma2 activation in platelets. Pflugers Arch 2009, 457:1173-1185. 10.1007/s00424-008-0573-7, 18704487.
15. Gao Y, Dickerson JB, Guo F, Zheng J, Zheng Y. Rational design and characterization of a Rac GTPase-specific small molecule inhibitor. Proc Natl Acad Sci USA 2004, 101:7618-7623. 10.1073/pnas.0307512101, 419655, 15128949.
16. Brandl R, Richter T, Haug K, Wilhelm MG, Maurer PC, Nathrath W. Topographic analysis of proliferative activity in carotid endarterectomy specimens by immunocytochemical detection of the cell cycle-related antigen Ki-67. Circulation 1997, 96:3360-3368.
17. Penz SM, Reininger AJ, Toth O, Deckmyn H, Brandl R, Siess W. Glycoprotein Ibalpha inhibition and ADP receptor antagonists, but not aspirin, reduce platelet thrombus formation in flowing blood exposed to atherosclerotic plaques. Thromb Haemost 2007, 97:435-443.
18. Toth O, Calatzis A, Penz S, Losonczy H, Siess W. Multiple electrode aggregometry: a new device to measure platelet aggregation in whole blood. Thromb Haemost 2006, 96:781-788.
19. Ingerman CM, Smith JB, Silver MJ. Direct measurement of platelet secretion in whole blood. Thromb Res 1979, 16:335-344. 10.1016/0049-3848(79)90081-1, 515999.
20. Saniabadi AR, Lowe GD, Belch JJ, Barbenel JC, Forbes CD. Effect of prostacyclin (epoprostenol) on the aggregation of human platelets in whole blood in vitro. Haemostasis 1984, 14:487-494.
21. Azim AC, Barkalow K, Chou J, Hartwig JH. Activation of the small GTPases, rac and cdc42, after ligation of the platelet PAR-1 receptor. Blood 2000, 95:959-964.
22. Soulet C, Hechler B, Gratacap MP, Plantavid M, Offermanns S, Gachet C, Payrastre B. A differential role of the platelet ADP receptors P2Y1 and P2Y12 in Rac activation. J Thromb Haemost 2005, 3:2296-2306. 10.1111/j.1538-7836.2005.01588.x, 16194206.
23. Cho MJ, Liu J, Pestina TI, Steward SA, Thomas DW, Coffman TM, Wang D, Jackson CW, Gartner TK. The roles of alpha IIb beta 3-mediated outside-in signal transduction, thromboxane A2, and adenosine diphosphate in collagen-induced platelet aggregation. Blood 2003, 101:26462651.
24. Rinder CS, Student LA, Bonan JL, Rinder HM, Smith BR. Aspirin does not inhibit adenosine diphosphate-induced platelet alpha-granule release. Blood 1993, 82:505-512.
25. Siess W. Molecular mechanisms of platelet activation. Physiol Rev 1989, 69:58-178.